• Hubert Chen resigns as Pfenex CMO ahead of NDA fiercebiotech
    August 20, 2018
    Hubert Chen, M.D., has resigned as CMO of Pfenex. The imminent departure leaves Pfenex without a CMO as it gears up to file a new drug application (NDA), although Chen will continue to advise the biotech as it interacts with the FDA.
PharmaSources Customer Service